CLBS logo

Caladrius Biosciences (CLBS) Accounts Payable

Annual Accounts Payable

$1.93 M
+$914.00 K+89.61%

December 31, 2021

Summary

Performance

1-Year Change

+89.61%

3-Year Change

+153.81%

5-Year Change

+44.01%

15-Year Change

+44.01%

CLBS Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$14.29 M
CLBS annual accounts payable is currently -86.46% below its historical high of $14.29 million

3-Year Low

$1.93 M
CLBS annual accounts payable is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
CLBS previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
CLBS next annual earnings announcement has not yet been scheduled

OtherCLBSbalance sheetmetrics:

Annual Accounts Receivable

-
CLBS annual accounts receivable value is unknown

Annual Total Liabilities

$5.01 M
CLBS annual total liabilities is $5.01 million

Annual Total Assets

$97.01 M
CLBS annual total assets is $97.01 million

Annual Current Assets

$96.18 M
CLBS annual total current assets is $96.18 million

Quarterly Accounts Payable

$974.00 K
-$123.00 K-11.21%

September 1, 2022

Summary

Performance

3-Month Change

-11.21%

1-Year Change

+26.82%

3-Year Change

+15.4%

5-Year Change

+10.73%

CLBS Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$19.40 M
CLBS quarterly accounts payable is currently -94.98% below its historical high of $19.40 million

3-Year Low

$697.00 K
CLBS quarterly accounts payable is currently +39.74% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2022
CLBS previous earnings announcement was published on Sep 1, 2022

Next Quarterly Earnings Report Date

N/A
CLBS next earnings announcement has not yet been scheduled

OtherCLBSbalance sheetmetrics:

Quarterly Accounts Receivable

-
CLBS quarterly accounts receivable value is unknown

Quarterly Total Liabilities

$6.76 M
CLBS quarterly total liabilities is $6.76 million

Quarterly Total Assets

$78.53 M
CLBS quarterly total assets is $78.53 million

Quarterly Current Assets

$77.29 M
CLBS quarterly total current assets is $77.29 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

CLBS Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+89.6%+26.8%
3 y3 years+153.8%+15.4%
5 y5 years+44.0%+10.7%

CLBS Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-49.6%-28.4%
5 y5-yearat high-47.3%-57.9%-93.4%
alltimeall time-86.5%-99.7%-95.0%-93.8%

Caladrius Biosciences Accounts Payable History

DateAnnualQuarterly
Sep 2022
-
$974.00 K(-11.2%)
Jun 2022
-
$1.10 M(+57.4%)
Mar 2022
-
$697.00 K(-64.0%)
Dec 2021
$1.93 M(+89.6%)
$1.93 M(+151.8%)
Sep 2021
-
$768.00 K(-38.2%)
Jun 2021
-
$1.24 M(-46.3%)
Mar 2021
-
$2.31 M(+127.0%)
Dec 2020
$1.02 M(-31.5%)
$1.02 M(-7.7%)
Sep 2020
-
$1.10 M(+86.7%)
Jun 2020
-
$592.00 K(+825.0%)
Mar 2020
-
$64.00 K(-95.7%)
Dec 2019
$1.49 M(+95.5%)
$1.49 M(+76.5%)
Sep 2019
-
$844.00 K(+51.0%)
Jun 2019
-
$559.00 K(+1.1%)
Mar 2019
-
$553.00 K(-27.4%)
Dec 2018
$762.00 K(-43.3%)
$762.00 K(+70.4%)
Sep 2018
-
$447.20 K(-11.6%)
Jun 2018
-
$505.70 K(-41.7%)
Mar 2018
-
$866.80 K(-35.5%)
Dec 2017
$1.34 M(-39.7%)
$1.34 M(+52.7%)
Sep 2017
-
$879.60 K(-21.0%)
Jun 2017
-
$1.11 M(-68.9%)
Mar 2017
-
$3.58 M(+60.7%)
Dec 2016
$2.23 M(-45.8%)
$2.23 M(-31.4%)
Sep 2016
-
$3.25 M(+11.8%)
Jun 2016
-
$2.90 M(-27.1%)
Mar 2016
-
$3.98 M(-3.0%)
Dec 2015
$4.11 M(-27.4%)
$4.11 M(+66.5%)
Sep 2015
-
$2.47 M(+8.9%)
Jun 2015
-
$2.27 M(-22.6%)
Mar 2015
-
$2.93 M(-48.3%)
Dec 2014
$5.66 M(+68.7%)
$5.66 M(+28.7%)
Sep 2014
-
$4.40 M(-19.7%)
Jun 2014
-
$5.48 M(+66.3%)
Mar 2014
-
$3.30 M(-1.8%)
Dec 2013
$3.35 M(+31.3%)
$3.35 M(+8.5%)
Sep 2013
-
$3.09 M(+28.2%)
Jun 2013
-
$2.41 M(+10.0%)
Mar 2013
-
$2.19 M(-14.2%)
Dec 2012
$2.56 M(+11.7%)
$2.56 M(-0.6%)
Sep 2012
-
$2.57 M(+18.4%)
Jun 2012
-
$2.17 M(-88.8%)
Mar 2012
-
$19.40 M(+748.0%)
Dec 2011
$2.29 M(-84.0%)
$2.29 M(-76.9%)
Sep 2011
-
$9.90 M(+6.8%)
Jun 2011
-
$9.27 M(-25.3%)
Mar 2011
-
$12.40 M(-13.2%)
Dec 2010
$14.29 M
$14.29 M(+87.4%)
DateAnnualQuarterly
Sep 2010
-
$7.62 M(-18.5%)
Jun 2010
-
$9.35 M(+5.0%)
Mar 2010
-
$8.91 M(+7.8%)
Dec 2009
$8.26 M(+1524.2%)
$8.26 M(+2316.3%)
Sep 2009
-
$342.00 K(+104.1%)
Jun 2009
-
$167.60 K(-77.4%)
Mar 2009
-
$742.60 K(+46.0%)
Dec 2008
$508.80 K(+221.0%)
$508.80 K(+48.3%)
Sep 2008
-
$343.20 K(+148.2%)
Jun 2008
-
$138.30 K(+38.6%)
Mar 2008
-
$99.80 K(-37.0%)
Dec 2007
$158.50 K(-57.4%)
$158.50 K(+5.1%)
Sep 2007
-
$150.80 K(-68.6%)
Jun 2007
-
$479.90 K(+144.8%)
Mar 2007
-
$196.00 K(-47.4%)
Dec 2006
$372.30 K(+44.9%)
$372.30 K(+518.4%)
Sep 2006
-
$60.20 K(-85.0%)
Jun 2006
-
$401.20 K(-11.9%)
Mar 2006
-
$455.40 K(+77.2%)
Dec 2005
$257.00 K(+7.9%)
$257.00 K(-63.7%)
Sep 2005
-
$707.60 K(+230.8%)
Jun 2005
-
$213.90 K(+4.7%)
Mar 2005
-
$204.30 K(-14.2%)
Dec 2004
$238.10 K(+170.9%)
$238.10 K(+4.7%)
Sep 2004
-
$227.40 K(+67.7%)
Jun 2004
-
$135.60 K(+8.1%)
Mar 2004
-
$125.40 K(+42.7%)
Dec 2003
$87.90 K(-74.5%)
$87.90 K(-7.9%)
Sep 2003
-
$95.40 K(-81.5%)
Jun 2003
-
$516.20 K(+20.8%)
Mar 2003
-
$427.40 K(+24.1%)
Dec 2002
$344.30 K(+163.6%)
$344.30 K(+29.0%)
Sep 2002
-
$266.90 K(+2.9%)
Jun 2002
-
$259.30 K(+61.8%)
Mar 2002
-
$160.30 K(+22.7%)
Dec 2001
$130.60 K(-9.8%)
$130.60 K(+20.5%)
Sep 2001
-
$108.40 K(+11.9%)
Jun 2001
-
$96.90 K(0.0%)
Mar 2001
-
$96.90 K(-33.1%)
Dec 2000
$144.80 K(-74.2%)
$144.80 K(-28.1%)
Sep 2000
-
$201.50 K(-1.2%)
Jun 2000
-
$203.90 K(+50.7%)
Mar 2000
-
$135.30 K
Dec 1999
$561.90 K(+319.6%)
-
Dec 1998
$133.90 K(+161.5%)
-
Mar 1998
$51.20 K(+944.9%)
-
Mar 1997
$4900.00(-97.3%)
-
Mar 1996
$183.10 K
-

FAQ

  • What is Caladrius Biosciences annual accounts payable?
  • What is the all time high annual accounts payable for Caladrius Biosciences?
  • What is Caladrius Biosciences annual accounts payable year-on-year change?
  • What is Caladrius Biosciences quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Caladrius Biosciences?
  • What is Caladrius Biosciences quarterly accounts payable year-on-year change?

What is Caladrius Biosciences annual accounts payable?

The current annual accounts payable of CLBS is $1.93 M

What is the all time high annual accounts payable for Caladrius Biosciences?

Caladrius Biosciences all-time high annual accounts payable is $14.29 M

What is Caladrius Biosciences annual accounts payable year-on-year change?

Over the past year, CLBS annual accounts payable has changed by +$914.00 K (+89.61%)

What is Caladrius Biosciences quarterly accounts payable?

The current quarterly accounts payable of CLBS is $974.00 K

What is the all time high quarterly accounts payable for Caladrius Biosciences?

Caladrius Biosciences all-time high quarterly accounts payable is $19.40 M

What is Caladrius Biosciences quarterly accounts payable year-on-year change?

Over the past year, CLBS quarterly accounts payable has changed by +$206.00 K (+26.82%)